APLS
Apellis Pharmaceuticals Inc
Price:  
16.70 
USD
Volume:  
2,649,924.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Apellis Stock Forecast & Price Target

Apellis Stock Price Forecast

The average stock forecast for Apellis Pharmaceuticals Inc (APLS) in the next 12 months is 42.84 USD. This price target corresponds to an upside of 156.53%. The range of stock forecasts for Apellis is 21.21 - 78.75 USD. Based on the ratings of 29 analysts, the consensus recommendation for Apellis is BUY.
Target Low Average Median High
Price (USD) 21.21 42.84 42.33 78.75
Upside 27.01% 156.53% 153.47% 371.56%

Recommendation Trends

The latest consensus rating for Apellis is "BUY". This is the average recommendation of 29 analysts: 0 strong sell, 0 sell, 9 hold, 10 buy, 10 strong buy. In the previous period, 28 analysts also majorly recommmended "STRONGBUY" for Apellis.

Apellis Financial Stock Forecast

Revenue This Year
808.37M
3.46%
from 781.37M
Revenue Next Year
993.02M
22.84%
from 808.37M
EPS This Year
-1.02
-36.04%
from -1.60
EPS Next Year
0.23
-122.49%
from -1.02